- Over 2 Million SOL Held with Approximately 95% Staked at ~7% Gross Annualized Yield
- Total Assets of $269.1 Million, Up from $7.3 Million at Year-End 2024
- Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto.com, BitGo, and Jupiter
NEW YORK, April 06, 2026 (GLOBE NEWSWIRE) — Sharps Technology, Inc. (“Sharps” or the “Company”), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the year ended December 31, 2025, and provided an update on the continued execution of its treasury and infrastructure strategy.
The Company entered 2025 as a capital-constrained medical device manufacturer and exited 2025 with what management believes is the strongest financial and strategic platform in the Company’s history. In a matter of months, Sharps launched a Solana-focused digital asset treasury strategy, accumulated more than 2 million SOL, established a recurring staking income stream with ~95% of our SOL actively staked at a ~7% gross annualized yield, eliminated unprofitable manufacturing overhead, restored positive working capital, substantially expanded stockholders’ equity, and repositioned the Company around a far more scalable and capital-flexible operating model.
“Our 2025 year-end results reflect a pivotal transition for Sharps Technology,” said Paul K. Danner, Executive Chairman. “During the year, we transformed the Company’s balance sheet, completed our strategic shift away from unprofitable legacy operating activities, established a treasury position of more than 2 million SOL, and laid the foundation for a more scalable and capital-efficient platform. As we move through 2026, we intend to build on a foundation that simply didn’t exist a year ago to grow the Company’s business.”
With legacy manufacturing activities being phased out and a sizable SOL treasury now in place, Sharps believes …